Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome | |
Schwartz, G. G.; Steg, P. G.; Szarek, M.; Bhatt, D. L.; Bittner, V. A.; Diaz, R.; Edelberg, J. M.; Goodman, S. G.; Hanotin, C.; Harr 更多 | |
刊名 | NEW ENGLAND JOURNAL OF MEDICINE |
2018 | |
卷号 | 379期号:22页码:2097-2107 |
DOI | 10.1056/NEJMoa1801174 |
URL标识 | 查看原文 |
公开日期 | [db:dc_date_available] |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/4583527 |
专题 | 山东大学 |
作者单位 | 1.Univ Colorado, Sch Med, Div Cardiol, Box B130, Aurora, CO 80045 USA. 2.Paris Diderot Univ, Sorbonne Paris Cite, Hop B |
推荐引用方式 GB/T 7714 | Schwartz, G. G.,Steg, P. G.,Szarek, M.,et al. Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome[J]. NEW ENGLAND JOURNAL OF MEDICINE,2018,379(22):2097-2107. |
APA | Schwartz, G. G..,Steg, P. G..,Szarek, M..,Bhatt, D. L..,Bittner, V. A..,...&Harr 更多.(2018).Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome.NEW ENGLAND JOURNAL OF MEDICINE,379(22),2097-2107. |
MLA | Schwartz, G. G.,et al."Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome".NEW ENGLAND JOURNAL OF MEDICINE 379.22(2018):2097-2107. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论